Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1532Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Smita S Mangalgi, Shivali V Gajul, Shivajirao T Mohite Sanjay M Wavare, Satish V Kakade. | - |
| dc.date.accessioned | 2019-12-27T10:49:41Z | - |
| dc.date.available | 2019-12-27T10:49:41Z | - |
| dc.date.issued | 2015-01 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1532 | - |
| dc.description.abstract | Background: β-lactamases viz., extended spectrum β-lactamase (ESBL), AmpC, and metallo β-lactamase (MBL) production in Klebsiella pneumoniae has led to a serious concern about septicemic neonates in Neonatal Intensive Care Units due to high resistance against commonly used antimicrobials. Purpose: To study the prevalence of ESBL, AmpC, and MBL production in K. pneumoniae isolates in neonatal septicemia, to check antimicrobial susceptibility to various drugs including tigecycline; and to assess burden of multiple drug resistance (MDR). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | AmpC, extended spectrum β-lactamase, septicemiaKlebsiella pneumoniae, metallo β-lactamase, neonatal | en_US |
| dc.title | Klebsiella Pneumoniae in Septicemic Neonates with Special Reference to Extended Spectrum β-lactamase, AmpC, Metallo β-lactamase Production and Multiple Drug Resistance in Tertiary Care Hospital. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Faculty of Microbiology | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.